SCHEMBL7175998

SCHEMBL7175998

Cc1cc(OCC(C)C)ccc1PC(=O)c1c(C)cccc1C.[LiH]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.39
FFAR1 O14842 2/20 0.38
PPARD Q03181 1/20 0.38
NR1H4 Q96RI1 2/20 0.38
FOS P01100 2/20 0.38
JUN P05412 2/20 0.38
ATM Q13315 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
PDK2 Q15119 1/20 0.37
TRIM24 O15164 1/20 0.37
MDM2 Q00987 1/20 0.36
MCL1 Q07820 1/20 0.36
KAT6A Q92794 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
BRAF P15056 1/20 0.35
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184492 0.92 KMT2A (0.39) XDHFFAR1NR1H4FOSJUN
SCHEMBL7176019 0.90 KMT2A (0.41) XDHFFAR1PPARDNR1H4FOS
SCHEMBL7188508 0.90 FOS (0.41) XDHFFAR1PPARDNR1H4FOS
SCHEMBL7188227 0.90 XDH (0.39) XDHFFAR1PPARDFOSJUN
SCHEMBL7189092 0.88 XDH (0.39) XDHFFAR1PPARDNR1H4FOS
Lithium SCHEMBL7188514 0.88 FFAR1 (0.39) XDHFFAR1PPARDNR1H4FOS
SCHEMBL7187020 0.88 MAPK1 (0.43) PPARDNR1H4ATMPDK2
SCHEMBL7179629 0.87 XDH (0.37) XDHFFAR1PPARDFOSJUN
SCHEMBL7188478 0.86 XDH (0.39) XDHFFAR1PPARDFOSJUN
SCHEMBL7182639 0.86 PDK2 (0.40) XDHFFAR1PPARDNR1H4FOS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 XDH 4277/4885FFAR1 671/4885PPARD 3776/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 XDH 4546/4885FFAR1 711/4885PPARD 3650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.